Literature DB >> 20830499

HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster.

J Verbeeck1, L Kwanten, F D'Heygere, A Beguin, S Michiels, I Desombere, G Leroux-Roels, P Lemey, F Nevens, M Van Ranst.   

Abstract

In order to study the hepatitis C virus (HCV) epidemiology in Flanders, Belgium, the HCV genotype of 2,301 patients diagnosed with HCV between 2001 and 2009 was determined. HCV genotyping was conducted using the Versant LiPA 1.0 or Versant LiPA 2.0 assay. To explore the transmission history of a remarkable cluster of the rarely found HCV genotype 5a, face-to-face interviews based on detailed questionnaires and maximum likelihood phylogenetic analysis were performed. HCV genotype 1 was the most prevalent genotype in all provinces, followed by HCV genotype 3 in East Flanders, Antwerp, Flemish Brabant and Limburg. In Brussels, HCV genotype 4 was the second most prevalent genotype. This observation is due to the immigration of patients from the Middle East and Africa. Remarkably, a cluster of HCV genotype 5a was found in West Flanders, where it represents the second most prevalent genotype, accounting for 26.2% of HCV infections. We could not identify one major transmission source explaining the whole HCV genotype 5a epidemic. Instead, several smaller possible transmission chains were identified and confirmed phylogenetically. Overall, the HCV genotype 5a epidemic in West Flanders seems to be mainly associated with blood transfusion and unsafe medical practices.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830499     DOI: 10.1007/s10096-010-1021-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Distribution of hepatitis C virus genotypes in viremic patients with beta-thalassemia.

Authors:  M Christofidou; C Lambropoulou-Karatza; G Dimitracopoulos; I Spiliopoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-09       Impact factor: 3.267

2.  Infection by genotype 5a of HCV in a district of southeast Spain.

Authors:  R Jover; J Pérez-Serra; F de Vera; J M Alamo; C Muñoz; C Yago; R Martínez-Ramírez; J V Vidal
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

Review 3.  Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.

Authors:  Peter Simmonds; Jens Bukh; Christophe Combet; Gilbert Deléage; Nobuyuki Enomoto; Stephen Feinstone; Phillippe Halfon; Geneviève Inchauspé; Carla Kuiken; Geert Maertens; Masashi Mizokami; Donald G Murphy; Hiroaki Okamoto; Jean-Michel Pawlotsky; François Penin; Erwin Sablon; Tadasu Shin-I; Lieven J Stuyver; Heinz-Jürgen Thiel; Sergei Viazov; Amy J Weiner; Anders Widell
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

4.  Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C.

Authors:  B Kleter; J T Brouwer; F Nevens; L J van Doorn; A Elewaut; J Versieck; P P Michielsen; M L Hautekeete; R A Chamuleau; R Brénard; N Bourgeois; M Adler; W G Quint; C M Bronkhorst; R A Heijtink; W J Hop; J Fevery; S W Schalm
Journal:  Liver       Date:  1998-02

5.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

6.  Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

Authors:  C Payan; F Roudot-Thoraval; P Marcellin; N Bled; G Duverlie; I Fouchard-Hubert; P Trimoulet; P Couzigou; D Cointe; C Chaput; C Henquell; A Abergel; J M Pawlotsky; C Hezode; M Coudé; A Blanchi; S Alain; V Loustaud-Ratti; P Chevallier; C Trepo; V Gerolami; I Portal; P Halfon; M Bourlière; M Bogard; E Plouvier; C Laffont; G Agius; C Silvain; V Brodard; G Thiefin; C Buffet-Janvresse; G Riachi; F Grattard; T Bourlet; F Stoll-Keller; M Doffoel; J Izopet; K Barange; M Martinot-Peignoux; M Branger; A Rosenberg; P Sogni; M L Chaix; S Pol; V Thibault; P Opolon; A Charrois; L Serfaty; B Fouqueray; J D Grange; J J Lefrère; F Lunel-Fabiani
Journal:  J Viral Hepat       Date:  2005-07       Impact factor: 3.728

7.  Investigating the origin and spread of hepatitis C virus genotype 5a.

Authors:  Jannick Verbeeck; Piet Maes; Philippe Lemey; Oliver G Pybus; Elke Wollants; Ernie Song; Frederik Nevens; Johan Fevery; Wayne Delport; Schalk Van der Merwe; Marc Van Ranst
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

8.  Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles.

Authors:  Joep de Bruijne; Janke Schinkel; Maria Prins; Sylvie M Koekkoek; Sem J Aronson; Marijn W van Ballegooijen; Hendrik W Reesink; Richard Molenkamp; Thijs J W van de Laar
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

9.  Genetic epidemiology of hepatitis C virus throughout egypt.

Authors:  S C Ray; R R Arthur; A Carella; J Bukh; D L Thomas
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

10.  Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.

Authors:  Liselotte van Asten; Inge Verhaest; Saida Lamzira; Ildefonso Hernandez-Aguado; Robert Zangerle; Faroudy Boufassa; Giovanni Rezza; Barbara Broers; J Roy Robertson; Raymond P Brettle; Jim McMenamin; Maria Prins; Alexandra Cochrane; Peter Simmonds; Roel A Coutinho; Sylvia Bruisten
Journal:  J Infect Dis       Date:  2004-01-08       Impact factor: 5.226

View more
  2 in total

1.  Distribution of HCV genotypes in Belgium from 2008 to 2015.

Authors:  Lobna Bouacida; Vanessa Suin; Veronik Hutse; Michaël Boudewijns; Reinoud Cartuyvels; Laurent Debaisieux; Emmanuel De Laere; Marie Hallin; Nicolas Hougardy; Katrien Lagrou; Els Oris; Elizaveta Padalko; Marijke Reynders; Gatien Roussel; Jean-Marc Senterre; Michel Stalpaert; Dominique Ursi; Carl Vael; Dolores Vaira; Jos Van Acker; Walter Verstrepen; Steven Van Gucht; Benoit Kabamba; Sophie Quoilin; Gaëtan Muyldermans
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

2.  Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir.

Authors:  Gretja Schnell; Preethi Krishnan; Rakesh Tripathi; Jill Beyer; Thomas Reisch; Michelle Irvin; Tatyana Dekhtyar; Liangjun Lu; Teresa I Ng; Wangang Xie; Tami Pilot-Matias; Christine Collins
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.